These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 19463687

  • 1. False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17alpha-hydroxyprogesterone (17-OHP) values.
    Fingerhut R.
    Steroids; 2009 Aug; 74(8):662-5. PubMed ID: 19463687
    [Abstract] [Full Text] [Related]

  • 2. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry.
    Janzen N, Peter M, Sander S, Steuerwald U, Terhardt M, Holtkamp U, Sander J.
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2581-9. PubMed ID: 17456574
    [Abstract] [Full Text] [Related]

  • 3. Neonatal screening for congenital adrenal hyperplasia in North-Eastern Italy: a report three years into the program.
    Cavarzere P, Camilot M, Teofoli F, Tatò L.
    Horm Res; 2005 Jul; 63(4):180-6. PubMed ID: 15818055
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls.
    Varness TS, Allen DB, Hoffman GL.
    J Pediatr; 2005 Oct; 147(4):493-8. PubMed ID: 16227036
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Corrected 17-alpha-hydroxyprogesterone values adjusted by a scoring system for screening congenital adrenal hyperplasia in premature infants.
    Lee JE, Moon Y, Lee MH, Jun YH, Oh KI, Choi JW.
    Ann Clin Lab Sci; 2008 Oct; 38(3):235-40. PubMed ID: 18715851
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Monitoring congenital adrenal hyperplasia using blood spot 17-hydroxyprogesterone assay.
    Santos CM, Abad LR, Cua SC, Domingo CF.
    Southeast Asian J Trop Med Public Health; 2003 Oct; 34 Suppl 3():174-8. PubMed ID: 15906729
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of single and multiple courses of prenatal corticosteroids on 17-hydroxyprogesterone levels: implication for neonatal screening of congenital adrenal hyperplasia.
    Gatelais F, Berthelot J, Beringue F, Descamps P, Bonneau D, Limal JM, Coutant R.
    Pediatr Res; 2004 Nov; 56(5):701-5. PubMed ID: 15371568
    [Abstract] [Full Text] [Related]

  • 13. No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening.
    Hird BE, Tetlow L, Tobi S, Patel L, Clayton PE.
    Arch Dis Child; 2014 Feb; 99(2):158-64. PubMed ID: 24225272
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of one-tier and two-tier newborn screening metrics for congenital adrenal hyperplasia.
    Sarafoglou K, Banks K, Gaviglio A, Hietala A, McCann M, Thomas W.
    Pediatrics; 2012 Nov; 130(5):e1261-8. PubMed ID: 23071209
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Rapid steroid hormone quantification for congenital adrenal hyperplasia (CAH) in dried blood spots using UPLC liquid chromatography-tandem mass spectrometry.
    Janzen N, Sander S, Terhardt M, Steuerwald U, Peter M, Das AM, Sander J.
    Steroids; 2011 Dec 11; 76(13):1437-42. PubMed ID: 21839763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.